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Structural  studies  of IgG  (7S  ~'2-globulin)  molecules  indicate  that  they  contain 
heavy and light polypeptide chains (1-5). Four antigenically different types of human 
IgG heavy chains (-y-chains)  have been detected (6, 7) and are called ~'2a-, ~%-, ~/~-e, 
and ~,~a-chains.  1 Two antigenically distinguishable  types of light chains,  designated 
K-and X-chains, are also present in the normal IgG population (8, 9). About 65 per cent 
of normal serum IgG molecules contain K-chains, 35 per cent contain X-chains  (8, 9), 
and  these  molecules  are  referred  to  respectively as  type  K  and  type L  IgG.  IgG 
molecules containing these types of heavy and light polypepfide chains are present in 
all normal sera. 
Two loci, Gin (10) and Inv (11), determine a series of IgG antigens, or factors, which 
are present in the sera of some normal individuals, but not of others. This polymor- 
phism of the human IgG population has been demonstrated by serological  tests.  Gm 
factors are  associated  only with heavy chains  of IgG molecules  (12-16)  while Inv 
factors are associated with light chains of IgG, IgA, IgM, and also with Bence Jones 
proteins (13-16). 
Gm and Inv factors have not been related  to heavy and light polypeptide chain 
subclasses of normal serum IgG, because the four types of heavy chains and the two 
types of light chains are all present simultaneously in normal sera and methods for 
isolating each of the types from such sera are not now available.  G myeloma (7S ~'2- 
myeloma) proteins, however, consist of molecules  that are antigenicaily much more 
homogenous than those of normal serum IgG. G myeloma molecules have been shown 
to contain either K- or X-chains, but not both (17-19), and only one of the four types 
of -},-chains (6, 7). These proteins thus afford an opportunity to study relationships be- 
tween Gm and Inv factors and antigenic subclasses of IgG heavy and light chains. 
The  distribution  of three  Gm factors  [Gin(a),  Gm(b),  and  Gm(f)]  2 in  myeloma 
proteins was studied by Kunkel a  al. (20) who found that these factors were restricted 
to molecules in only two of the four ~,-chaln subclasses,  qt~b-Proteins (Group We) were 
either Gin(a+)  or Gm(f+) and never Gm(b+). ~%-Proteins (Group Vi) were either 
Gm(b+) or Gm(-). 
* This work was supported  in part by a United  States Public Health Service grant GM- 
07214. 
1  Alternative terminology for heavy-chain antigens: "Y2~, Ne; q~2b, We; ~/2o, Vi; 7~d, Ge (6). 
2 For comparison with Gm terminology used in this paper see Table I. 
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The present report contains an analysis of 89 G myeloma proteins, isolated 
from the sera of 1 Chinese, 60 white, and 28 Negro patients, that were classified 
according to "},-chain and light-chain antigens and tested for eight Gm factors 
[Gm(a),  Gin(x),  Gm(b2),  Gm(f),  Gm(bl),  Gm(b3),  Gin(b4),  Gm(c)]  and  two 
Inv factors [Inv(1),  8 Inv(b)].  * In addition, two  "heavy-chain" disease proteins 
(21-23) were studied. Results were examined for relationships between the ex- 
pression of these 10 genetically determined factors and the antigenic subclasses 
of heavy and light polypepfide chains. 
Materials and Methods 
Antisera.--(a) Antisera  specific for human IgG, IgA, IgM, type K  (type I), and type 
L  (type H) determinants were produced in rabbits (24); and (b) "Y2~-, ~/2b-, Tso-, and T2a- 
anfisem were obtained from rhesus monkeys repeatedly injected intramuscularly with either 
pooled normal human IgG, or isolated G myeloma proteins emulsified in complete Freund's 
adjuvant. All monkey anfisem  were absorbed  with myeloma proteins  of  known ~/-chain 
characteristics to render them specific  for T-chain subclass typing (7). 
Immunodiffusi~.--Immunoelectrophoresis  and  Ouchterlony  analyses  were performed 
with standard techniques using 1.5 per cent agar noble (Difco Laboratories, Inc., Detroit). 
Barbital buffer (pH 8.5, 0.045 ~) was used for immunoelectrophoresis; Ouchterlony plates 
were prepared with 0.07 ~ NaCI, 0.03 M  phosphate (pH 8) buffer. 
Isolation and Characterization of G Mydoma Proteins.--Most proteins were isolated from 
either serum or plasma by zone electrophoresis (24), and several were prepared by DEAE- 
cellulose chromatography  (24). Protein concentrations were calculated from optical density 
at 280 m# using an extinction coefficient, ~1~'1  emPer  een* of 13.3. All isolated proteins were anti- 
genicaUy characterized and analyzed for purity with  Ouchterlony tests.  Each protein was 
examined at the highest available concentration (usually 10 to 30 mg/ml) and also at 1 mg/ml, 
with  six antisera  (four T-chain antlsera  and two light-chain antisera).  Tests at the lower 
concentration  permitted  characterization  of the major component isolated, while those at 
higher concentrations yielded an estimation of the amount of contaminating IgG of other 
~'-chain and light-chain types. When indicated, the highest available concentration was also 
tested for the presence of IgA and IgM by Ouchterlony analysis using the appropriate specific 
anfisera. All of the eight possible combinations of 7-chains and light chains have been identi- 
fied (Table II), but type L "ySd-protein  was not available for isolation. "Heavy-chain" disease 
proteins Cr (from a Negro patient) and Zu (from a white patient) were gifts from Dr. E. C. 
Franklin and Dr. E. Osserman respectively. 
Gm and Inv Typing.--Reagents used for typing the G myeloma and "heavy-chain" disease 
proteins are shown in Table I. All typing except for Gm(b  2) and Inv(b) was done on micro- 
flocculation slides as previously described (25). Tests  for these  two factors were done in 
10 X  70 mm test tubes  (26). Antibody Lue., used for detecting Inv(b), was a euglobulin 
precipitate prepared by dialysis against cold distilled water of a serum sample obtained from 
s Inv(1) is a genetic factor that is present whenever Inv(a) is present,  but that may also 
be found in the absence of Inv(a). 
4 The World Health Organization, Scientific Group on Genes, Genotypes and Allotypes of 
Immunoglobulins, has discussed a new notation for genetic factors of human immunoglobu- 
lins. The new notation substitutes numerical for alphabetical designations (Table I). As this 
notation is still under discussion, the present paper has used old designations and included 
proposed new designations only in tables of results. W.  D.  TERRY,  J.  L.  FAHEY,  AND  A.  G.  STEINBERG  1089 
Luc. 53 days after a transfusion. Although this serum lacked anti-Inv(b) activity, the euglob- 
ulin precipitate,  dissolved in 0.1 ,~ tris-HC1 buffer pH 8, had activity identical with that of 
pretransfusion sera. All tests were done against group O R1R  I blood cells from the same donor. 
The cells were coated with the appropriate anti-D serum by incubating a mixture of one drop 
of washed packed  RBC with two drops of anti-D and  seven drops of saline at 37°C for 2 
hours. Just before use, the coated cells were washed four times in normal saline and suspended 
at 0.3 per cent for the slide tests, which were read under a dissecting microscope, and at 1.5 
per cent for the tube tests, which were read with the naked eye. All samples were tested at 
serial twofold dilutions. Initial protein concentrations were 2 mg/mi. Those samples scored 
as negative were negative at the first dilution (1 mg/ml). Inhibition titers are reported as the 
TABLE I 
Reagents Used to Detect 8 Gm and 2 Inv Factors 
Genetic  factor terminology 
Current 
Gin (a) 
Gm (x) 
Gm (b~)~ 
Gm (f)§ 
Gm (b)  and 031) 
Gm (b  3) 
Om (b  4) 
Gm (c) 
luv (1) 
Inv (b) 
Suggested 
Gm (1) 
Gm (2) 
Gm (3) 
Gm (4) 
Gm (5) 
Gm (13) 
Gm (14) 
Gm (6) 
Inv (t) 
Inv (3) 
Genetic typing reagent dilutions 
Agglutinator 
Wils. 
Tay. ~9. 
Da. 
A.J. ~ 
Dr. ~,~ 
Th. 
Bu. 
Ste. 
Math. 
Luc. euglobulin 
Anti-D* 
Rh 251 
Ham. 
Roe. 
¢¢ 
V.S. 
tt 
eg 
War. 
Roe. 
Ham. 
* All anti-D reagents used at ~,~ dilution. 
:~ Tube tests; all others, slide tests. 
§ Either very similar to or identical with Gm (b2). 
reciprocal of the last dilution (of a  2 mg/ml solution)  giving a  2+  agglutination when the 
uninhibited control gave a 4+ agglutination (Appendix). Gm and Inv typing and assignment 
of phenotypes were done in Cleveland without knowledge of "y and light-chaln types of the 
myeloma proteins which were determined in Bethesda. Similarly, ~, and l~ght-chain  types were 
determined without knowledge of Gm and Inv types. Results of the Gm and Inv tests, and 
the phenotype assignments for all proteins are listed in the Appendix according to "y-chain 
and light-chain types and the race of the donor. Proteins 4, 28, 30, 32, and 90 could not be 
assigned  definite phenotypes because of contamination  of the myeloma protein with non- 
myeloma IgG, and these phenotypes are indicated as question marks. 
RESULTS 
Classification of G myeloma Proteins.--A total of 89 G myeloma proteins were 
isolated and analyzed for heavy and light chain antigenic characteristics (Table 
II). Every protein could be identified as belonging to one "/-chain subclass and 
as having light chains of one type. The frequency of "/-chain antigens was ")'~, 1090  GM:  AND  INV  FACTORS 
19 per cent; "r~b, 67 per cent; 3'2o, 11 per cent; and "r2a, 3 per cent. These pro- 
teins represent a selection, since all "y~-, "y~-, and T2a-myeloma sera available 
in sufficient quantity were fractionated, while only some T2b-myeloma sera were 
fracfionated. A larger, unselected panel of 191 G myeloma sera (from which the 
89 proteins were selected) contains 11 per cent Th-, 77 per cent ~%-, 9 per cent 
~/2¢, and 3 per cent "y~-myeloma proteins (Table II). The series of isolated pro- 
teins is therefore weighted in favor of the less commonly occurring subclasses. 
Absolute concentrations of the four subclasses of IgG in normal sera are not 
yet known, but preliminary quantitative studies indicate that the relative con- 
TABLE H 
"y-Chain and Ligkt-Ckain Types  f G Mydoma Proteins and Serums 
~/-Chain  Light-chain  89 Isolated G myeloms  proteins  191 G myeloms serums 
"y2s (Ne) 
"y2s (We) 
"y~ (Vi) 
"y~ (Ge) 
K*  11 
10 
I¢ 
X 
44  104 
15  43 
4  9 
6  8 
3  5 
0  1 
* K  light chains determine that a molecule  is type K (type I); ~  light chains determine 
that a molecule  is type L (type II). 
centrafions parallel the frequency with which the four subclasses occur in the 
tmselected series (27). 
Light chain typing revealed that 67 per cent of the proteins were type K and 
33 per cent type L  (Table II). This 2:1 ratio is similar to the relative propor- 
tions of type K  and type L reported in other collected series of G myeloma pro- 
teins (17-19). Of the four 3,-chain subclasses, only 3,,b-proteins have an approx- 
imately 2:1  ratio of type K  to type L. The 3'~- and "y,¢proteins have a  1:1 
ratio of K- to X-chains (Table II). This 1:1 ratio may be due to the relatively 
small number of proteins tested, or it may indeed reflect an equal frequency of 
K- and X-chains  associated with  these */-chain forms, in contrast to  the  3:1 
K:X ratio found with 3%-chains.  The x  2 test  comparing light-chain  types of 
147 "y2b-proteins with light-chain types of 38 q/2~- and T2¢proteins indicate that 
the observed differences in K:]k ratios are unlikely to be due to chance alone 
(0.05  ~  p  >  0.02). The very small series of ~/~i-myeloma  proteins has a pre- 
ponderance of type K molecules. W.  D.  TERRY,  J.  L.  FAHEY,  AND  A.  G.  STEINBERG  1091 
Correlations  between 6m Factors and "y-Chain  Subdasses.-- 
3'~- and "y~a-Myeloma proteins: No  Gm  factors were detected  in any of the 17 
3%- and  three 3,~-myeloma  proteins  (Tables  III  and  IV,  Appendix).  Tests  on 
two of the preparations  (No. 30  and No.  32)  showed  low fiters for several Gm 
TABLE  HI 
Gm and In~ Phenotypes of 89 G Mydoma Proteins Classified by ~/ and Light-Chain 
Types and by Race of Donor 
~-Chain  ~.ha~t 
Current  Suggested  No. of Samples 
Gin  Inv  Gm  Inv  White  Negro  Chinese 
3% (Ne)  g  --*  --  --  --  7  1  0 
?*  --  ?  --  1  0  0 
X  ....  4  3  0 
?  ?  ?  ?  0  1  0 
'Y~b (We)  g  b 2  b  3  3  13  0  0 
b 2  --  3  --  4  0  0 
b ~  1  3  1  1  1  0 
a  b  1  3  6  6  0 
a  1  1  1  0  4  0 
a  --  1  --  0  6  0 
ax  b  1,  2  3  1  0  0 
ax  --  1,  2  --  1  0  0 
?  ?  ?  ?  0  1  0 
X  b ~  --  3  --  5  0  0 
a  --  1  --  5  2  0 
ax  --  1,  2  --  2  0  0 
?  ?  ?  ?  1  0  0 
~2e (Vi)  b L8,4  b  5,  13,  14  3  1  1  0 
b 1,8,4  --  5,  13,  14  --  1  0  0 
b 8  --  13  --  0  0  1 
b L3,4  --  5,  13,  14  --  3  0  0 
b t,a,4  ?  5,  13,  14  ?  1  0  0 
bXc  --  5,  6  --  0  1  0 
b 1' 4c  --  5,  14,  6  --  0  1  0 
~/~d (Ge)  r  ....  3  0  0 
Totals...  60  28  1 
* Inall Tables:  --  indicates negative test result,  ? indicates phenotype not assigned be- 
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factors and their  Gm and Inv phenotypes are recorded as uncertain. 0uchter- 
lony analysis of these preparations demonstrated molecules of heavy-chain sub- 
classes  other than 72a. The positive Gm results  therefore are ascribed to con- 
tamination. While the "ru- and 7~i-proteins lacked Gm antigens, all proteins of 
the other "r-chain subclasses contained at least one Gm antigen. 
7~-Myeloma  proteins:  Twenty-nine  7~b-proteins  were  Gin(a+),  4  were 
Gm(a  +  x+),  and  24 were  Gm(b~+)  (Tables  III and  IV, Appendix).  Two 
preparations  (No.  4  and No.  90)  were  apparently  Gm(a  +  b2+),  but  these 
TABLE IV 
Summary of 7-Chains and Gm Phenotypes 
Gm phenotype  No. of samples 
~-Chains 
Current  Suggested  White  Negro  Chinese 
"r2~ (Ye) 
"r2b (We) 
72e (Vi) 
? 
b  2 
8. 
ax 
? 
bl, a, 4 
blc 
b 1, 4  C 
b  8 
? 
3 
1 
1,  2 
? 
5,  13,  14 
5,  6 
5,  14,  6 
13 
11 
1 
23 
11 
4 
1 
1 
18 
0 
1 
1  0 
1  0 
1  0 
0  1 
72d (Ge)  --  --  3  0  0 
Totals .............................................  60  28  1 
samples were shown to be heavily contaminated with non-myeloma IgG. Un- 
fortunately, both donor patients are dead and no additional serum is available 
for refractionation. The phenotypes of protein samples 4 and 90 therefore could 
not be definitely established.  If these proteins are excluded neither Gm(a) nor 
Gin(x) were found in Gin(b2+) proteins. These findings confirm the observa- 
tions of Kunkel et al.  (20). 
There was complete concordance between Gm(b  2) and Gm(f) reactions among 
the 87 myeloma proteins tested for both (51 of the 72b-myeloma proteins, and 
26 other myeloma proteins). Tests for Gm(f) were not performed on 12 proteins 
because  of reagent  shortages.  These  results  and  those  from  tests  of  normal 
sera  (28)  suggest  that  Gm(b  *)  and  Gm(f)  are  very similar,  if  not  identical 
genetic factors. W. D. TERRY, J. L. ~AII~Y, AND  A. G. STEINBERG  1093 
7~-Myeloma proteins: Seven of 10 proteins were Gm(b  1, 8.4+). One 7so-pro- 
tein (No. 88) was Gm(bS-t-).  This myeloma protein, obtained from the serum 
of the only Chinese patient available, provides further evidence for the exist- 
ence in some Mongoloids of an allele determining Gm(bS-k)  in the absence of 
Gm(bl), Gm(b  2) and Gm(b  4)  (29). 
Gin(c)  was detected only in 7~o-myeloma proteins. One 7,~-protein from a 
Negro patient (No. 63) was positive for factors Gm(b  1) and Gin(c), and another 
Negro myeloma protein (No. 71) was Gm(b  1, 4_[_ cq-). Both phenotypes are of 
interest in  that they establish for  the first time a  relationship between the 
genetic factors Gin(c) and 7zcheavy chains. The Gm(b  1, *-t- c-}-) protein is of 
special importance since it suggests the existence of a Gm allele previously un- 
detected by studies of normal Negro sera (29). 
"Heavy-chain" disease proteins: Two proteins,  Cr and Zu, from patients with 
"heavy-chain" disease were tested for Gm and Inv factors. "Heavy-chain"  dis- 
ease proteins appear to be very similar, if not identical, to the Fc fragment that 
is obtained after papain digestion of IgG (21-23). Protein Zu has 72~-antigenic 
determinants and is Gm(b  1, 3.4_k)" The 7-chain antigenic determinants of pro- 
tein Cr have not been clearly identified with monkey anfisera. This protein, 
however, appears to be of type 7,a. The Gin data are in accord with this impres- 
sion since Cr was negative for the eight Gm factors. This finding differs from 
previous reports (21, 23) which described Cr as being Gm(b -t- e-k-). Tests for 
Gin(e)  were not performed since reagents were not available for this factor. 
Previous detection of Gin(b) may have been due to contaminating IgG. As was 
expected, both  "heavy-chain"  disease proteins,  which lack  light chains,  are 
Inv(1 -- b--). 
Correlation Between Inv Factors and Mydoma Proteins with ~- (Type K) and 
)~- (Type  L)  Light Polypeptide Chains.--Inv  factors were detectable only in 
type K protein preparations. Of 60 type K proteins, 6 were Inv(lq-),  28 were 
Inv(b-b), and 25 were Inv(1 -- b--). Inv(1 -b b-b)  proteins were not observed 
(Table V). None of the 29 type L proteins were definitely positive for Inv(1) 
or Inv(b). Three of these  (Nos. 4,  32, and 90)  could not be classified due to 
contamination with non-myeloma IgG. We emphasize that classification was 
done without knowledge of the light-chain type. Protein No. 28 was initially 
classified as Inv(bq-),  but was subsequently shown to contain non-myeloma 
IgG of type K. 
Because of the low frequency with which Inv(1) was detected in the type K 
myeloma proteins (one of 39 from whites and 5 of 19 from Negroes), 65 of the 
sera from which these proteins were obtained were tested for Inv(1). Inv(1)  was 
detected in 9 of 47 white sera (19 per cent) and 10 of 18 Negro sera (55 per 
cent). This does not differ from the expected frequencies of 20 per cent and 50 
per  cent  Inv(l+)  sera in normal white and Negro populations respectively 
(25). The low rate of occurrence of Inv(l+) type K myeloma proteins therefore 1094  GM  AND  INV  FACTORS 
does not reflect an unusual genetic distribution in the myeloma patients from 
whom these proteins were obtained. 
Correlations  Between Inv Phenotype and "y-Chain  Subclasses.--Of  the 47 ge- 
netically classifiable  type K  "y~s- and  "yso-myeloma proteins,  34  were  either 
Inv(l+)  or  Inv(b+)  (Table Ill).  By contrast, all of 12  classifiable  type K 
"y2~- and "y~-proteins were Inv(1 -  b--). Although the number of proteins stud- 
ied is relatively small, it is statistically unlikely that these 12 type K "y2~- and 
"y~-proteins are Inv(1 -- b--) due to chance alone (p =  0.000005). 
TABLE V 
Summary of Light Chains and Inv Phenotypes 
Inv phenotype  No. of samples 
Light chain 
White  Negro  Chinese  Current  Suggested 
1  1 
b  3 
?  ? 
?  ? 
1 
21 
17 
o 
19 
2 
Totals...  60  28  I 
DISCUSSION 
These data confirm and extend the observations of Kunkel et al. (20) relating 
Gm factors (a),  (b0,  and (f)  to the four "y-polypeptide chain subclasses of G 
myeloma proteins. New information relating the Gm factors (b2), (x), (bS), (b4), 
and (c)  and the Inv factors (1) and (b)  to the four "y-chain subclasses  and  to 
the two types of light polypeptide chains (K and X) is presented. 
None of the eight Gm factors was detected in intact "y,a-  or "y~-myeloma  pro- 
teins.  Proteins  of these "y-chain subclasses may contain as yet unrecognized 
genetic factors under the control of the Gill locus, or other known Gm factors, 
such as Gin(r), Gm(p), Gin(e), etc. that could not be assessed.  Alternatively, 
"Y2~- and "y2a-proteins may contain genetic factors controlled at a different locus, 
or they may not have any "y-chain genetic polymorphism. Another possibility 
is that "y,a- and "y~a-molecules  may contain "y-chain genetic factors that are un- 
detectable in the intact molecule because of tertiary or quaternary structural 
relationships. Serologic tests of "y-chains isolated from these molecules should be 
performed. 
A single "y-polypeptide chain may contain multiple genetic factors. The ob- W.  D.  TERRY,  3.  L.  ~AHEY,  AND  A.  G.  STEINBERG  1095 
servation of Gm(a -b x-b) T~b-proteins confirms reports (30-33)  that both fac- 
tors may be detected in a single myeloma protein. New examples  of multiple 
factor expression  are the T2c-proteins that are Gm(b  z, 3, 4_l_  ) and the combina- 
tions of Gm(b  1, 4) and Gm(b  1) with Gm(c). 
Certain facts concerning Gm factors and myeloma proteins can be interpreted 
in view of the data in this report. Three of the G myeloma proteins from Negroes 
(Nos. 62, 63, and 71) are Gm(bl-t-). Although almost all American Negro sera 
are Gm(a -[- blq-), Negro G myeloma proteins reported previously had been 
Gm(a-k)  and none had been Gm(bl-[-). Previous failures  to detect Gm(bIW) 
proteins probably reflect the small numbers of myeloma proteins from Negroes 
that had been typed for Gm factors. The Gm(b  1) factor is expressed only in 
molecules containing T~o-chalns. Only 9 per cent of G myeloma proteins are of 
subclass T~, hence,  less than 10 per cent of Negro G myeloma proteins would 
be expected to be Gm(bl-b). 
It is of interest that myeloma proteins from Negro patients are phenotypically 
like those from white patients  for the  Gm(a),  Gm(bl),  Gm(bS), and  Gm(b  4) 
factors. These factors, however, are inherited as a single unit in Negroes while 
Gm(a) on the one hand and Gm(b  1, 8.4) on the other are inherited as separate 
units in whites. This suggests that the expression of these factors is dependent 
on the type of y-chain produced by the myeloma cells, as well as on the Gm 
genotype of the patient. The Gm genotype gives the cell the potential to pro- 
duce one or more Gm factors, while the factors actually produced are dependent 
on the kind of y-chain formed by the cell. 
Gm(c) is detected only in Negro populations and is found in less than 30 per 
cent of sera in the American Negro population.  Gm(c-b) myeloma proteins, 
which also are members of the Tso-subclass, should therefore be detected even 
less frequently than  Gm(bX-[  -) myeloma proteins. This proved to be the case 
with the finding of two Gm(c-k) myeloma proteins. 
A  clear  relationship has been demonstrated between T~b-myeloma proteins 
(polypeptide chains)  and  Gm factors  (a),  (x),  (b~), and  (f)  and between T~- 
myeloma proteins (polypeptide chains)  and Gm factors (hi),  (b~), (b4), and (c). 
There  are various interpretations  of how the observed relationships between 
Gm factors and different forms of T-polypeptide chains  might influence  theo- 
retical conceptions of the Gm locus. Discussion of these concepts is outside the 
scope of this report, and a more complete exposition of the problem has been 
presented elsewhere (20, 28). 
Inv factors were detected only in type K myeloma proteins. All K-polypeptide 
chains  must share  a  common amino  acid sequence which determines  the  K- 
specific configuration.  In addition, they must contain highly variable segments 
which are responsible for individual specific configurations  (34, 35). Presumably, 
Inv factors are present in the common segment. Approximately 40 per cent of 
the type K proteins were Inv(1 -- b--). Light chains of these proteins may con- 1096  GI~  AND  INV  :FACTORS 
tain Inv factors that have not yet been recognized or defined. Another possibil- 
ity is that these light chains represent a subclass of K-chains under the genetic 
control of another locus. 
All of the  type L  myeloma proteins that could be unequivocally classified 
were Inv(1 --  b--). Three instances of type L  G myeloma proteins containing 
Inv factors have been reported (13,  31,  36). Inadequacies in some aliquots of 
the Inv(b) agglutinator serum (Luc.), however, may have contributed to these 
findings. The recent report of Lawler and Cohen (36)  stated that the isolated 
X-chains of one G myeloma protein were Inv(b+). The anti-Inv(b) serum used 
in these tests was obtained from Luc. shortly after a transfusion, and was sub- 
sequently noted to give unreliable test results. Through the kind cooperation 
of Dr. Lawler and Dr. Cohen, one of us (A.G.S.) retested these X-chains with 
an aliquot of reliable anti-Inv(b) and the chains were clearly Inv(b-). In view 
of this and the data in the present study, it seems unlikely that type L  G mye- 
loma  proteins  contain  Inv  factors  detectable  in  the  intact  molecule. Light 
chains isolated from Inv(1  --  b--)  type L  G myeloma proteins may possibly 
contain Inv factors that are not detectable when those light chains are folded 
into the intact IgG molecule. This also is not likely, since X-Bence Jones pro- 
teins, which appear to be very similar to light chains isolated from myeloma 
proteins, have almost all been Inv(1 --  b--)  (13,  31, 37). 
Gm and Inv factors are controlled by independent genetic loci. Because the 
loci are independent, it might be expected that the occurrence of Gm and Inv 
factors in a  single IgG molecule would also be an independent phenomenon, 
i.e.,  that the occurrence of Inv factors in a molecule would be independent of 
the occurrence of Gm factors. The current data showing that type K ~/2~- and 
q,2a-proteins which lack Gm antigens are also Inv(1 -  b--) cast some doubt on 
this assumption. This finding may be due to genetic control in the sense that 
cells synthesizing "y2~- or qc~a-heavy chains might not be able to synthesize K- 
chains expressing Inv factors. Alternatively, the conformation of K-chains when 
folded with ~/2~- or "y2d-chains  may be such that Inv determinants are blocked or 
distorted. 
All the data in the present report are derived from studies of G myeloma pro- 
teins. Proof that the observed relationships are also true for normal serum IgG 
must await isolation of 3%-, "Y2b-, 3'2c, and ~/~-globulins  and  K- and X-chains 
from normal serum. 
SUMMARY 
Human G myeloma (7S ~-myeloma) proteins were investigated for relation- 
ships between Gm and Inv genetic factors and the different antigenic types of 
heavy polypeptide chains (3'-chains) and light polypeptide chains. 
Myeloma proteins were isolated from the sera of 1 Chinese, 60 white and 28 
Negro individuals. These 89 proteins were tested for eight Gm factors [Gin(a), W. D. TERRY,  ~'. L. FAHEY,  AND A. G. STEINBERG  1097 
Gm(x),  Gm(b2),  Gm(f), Gm(bl),  Gm(b3),  Gm(bg, and  Gm(c)], and  two Inv 
factors [Inv(1)  and Inv(b)]. Results of the tests were correlated with the four 
")'-chain subclasses (~'2a,  ~'2b, ~%, and "Y2d) and the two types of light polypeptide 
chains, K-chains  (type K  or I) and X-chains (type L  or II) found in human IgG 
molecules. 
1.  Gm factors  were limited  to myeloma proteins  with  heavy polypeptide 
chains of the ~%- and ~%-subclasses. No Gm factors were detected on 5%- and 
~,2d-myeloma  proteins or on a  "heavy-chain" disease protein of subclass "Y2d. 
2.  %b-Proteins  were positive  for  at  least  one  Gm factor  and  were  either 
Gm(a-l-), Gm(a  -b x-}-),  or Gm(b2-}  - f+). 
3.  "y2o-Myeloma  proteins,  and  one 72¢"heavy-chain"  disease protein,  were 
positive for at least one Gm factor and contained various combinations of fac- 
tors Gm(b*), (b3), (b4), and (c). Myeloma proteins from 3 Negroes were included 
in this group. 
4.  Inv factors  (1)  and  (b)  were limited  to myeloma proteins  with  K-light 
polypepfide chains. These  Inv factors were not  detected  on proteins with k- 
light polypeptide chains. 
5.  Most (70 per cent) of the 3%- and 7~o-proteins with K-chains  were Inv(l+) 
or Inv(b-[-). None of the "y~- or 7~-proteins with K-chains,  however, contained 
these Inv factors. 
The authors gratefully acknowledge  the skilled  technical assistance of Miss Harriet Granger, 
Mrs. Elizabeth Kurczynski, Miss Barbara  Plocinik, and Miss Janet  Wilson. We also wish 
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Note  Added  in  Proof.--Another  myeloma protein,  from  Chinese  patient  W.P. 
(No. 92) has recently been studied in our laboratories. The serum phenotype is Gm 
(a+, b*q  -, blq  -, bS-b, b4q  -, x-), Inv(1 -  b+). The isolated myeloma protein is of 
subclass 7*b, type K. Titration data for Gm factors are: Gm(a), 256;  Gm(b~), 256; 
Gin(b1),  -;  Gm(b  ~)  -;  Gm(b  4)  -. The phenotype of this mongoloid myeloma pro- 
tein is clearly Gm(a -b b ~ +). A similar finding,  based on titration of a mongoloid 
myeloma serum, has recently been reported (38). This combination of Gm factors in 
a  myeloma protein indicates that the genetic information for these factors may be 
carried on the  same chromosome and raises the  question  of why Gm(a  +  b ~  +) 
molecules are not observed in myeloma proteins from Caucasoids. 
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